Lapix Therapeutics Inc.
Clinical trials sponsored by Lapix Therapeutics Inc., explained in plain language.
-
New pill for eczema and psoriasis enters early safety testing
Symptom relief Recruiting nowThis early-stage study tests an experimental oral drug, LPX-TI641, in 48 adults with atopic dermatitis (eczema) or psoriasis. The main goal is to check if the drug is safe and tolerable compared to a placebo over 28 days. Researchers will also measure how the drug moves through t…
Phase: PHASE1 • Sponsor: LAPIX Therapeutics Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 08:05 UTC
-
New arthritis drug candidate enters early human safety testing
Symptom relief Recruiting nowThis early-stage study tests an experimental drug called LPX-TI641 in 48 adults with rheumatoid arthritis or psoriatic arthritis. Participants take the drug or a placebo daily for 28 days. The main goal is to check if the drug is safe and tolerable, and how it moves through the b…
Phase: PHASE1 • Sponsor: LAPIX Therapeutics Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 07:59 UTC